BRIEF-Entrada Therapeutics Inc On Track To Report Elevate-44-201 Cohort 1 Data In Q2 2026, Cohort 2 Data By End Of Year
Entrada Therapeutics Inc +1.01% Pre
Entrada Therapeutics Inc TRDA | 14.03 14.03 | +1.01% 0.00% Pre |
Feb 17 (Reuters) - Entrada Therapeutics Inc TRDA.O:
ENTRADA THERAPEUTICS INC - ON TRACK TO REPORT ELEVATE-44-201 COHORT 1 DATA IN Q2 2026, COHORT 2 DATA BY END OF YEAR
ENTRADA THERAPEUTICS INC - INTENDS TO OPEN EXPANSION COHORT LATER THIS YEAR IN ELEVATE-44-201 STUDY
Source text: ID:nGNX25yJ7q
Further company coverage: TRDA.O
